triamcinolone acetonide has been researched along with Retinal Diseases in 135 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (2.96) | 18.7374 |
| 1990's | 6 (4.44) | 18.2507 |
| 2000's | 77 (57.04) | 29.6817 |
| 2010's | 45 (33.33) | 24.3611 |
| 2020's | 3 (2.22) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, SH; Lee, DY; Nam, DH | 1 |
| Abdin, AD; Löw, U; Munteanu, C; Seitz, B; Wykrota, AA | 1 |
| Kalavar, M; Kuriyan, AE; Sridhar, J; Watane, A; Yannuzzi, NA | 1 |
| Chaugule, SS; Finger, PT; Kaplan, RI | 1 |
| Guo, C; Qiu, J; Yang, L; Zhu, L; Zhu, R | 1 |
| Fine, HF; Grossniklaus, HE; Prenner, JL; Reshef, ER; Roth, DB; Shah, SP | 1 |
| Ganne, P; Krishnappa, NC | 1 |
| Adam, MK; Dunn, JP; McMahon, JF | 1 |
| Minckler, D; Small, KW; Walsh, TJ | 1 |
| Araujo, J; Chung, SH; Gillies, MC; Lee, SR; Shen, W; Zhu, L | 1 |
| Kunavisarut, P; Pathanapitoon, K; Rothova, A | 1 |
| Han, JH; Kim, SY; Park, YH; Shin, JA; Yang, JW; Yum, HR | 1 |
| Chen, Y; Cheng, L; Han, Y; Mao, J; Shen, L; Sun, S | 1 |
| Hasegawa, T; Masuda, N; Ogata, N | 1 |
| Chau, F; Goldstein, DA; Liu, D; Munk, MR; Rademaker, A; Ram, R; Schmidt-Erfurth, U; Setlur, V | 1 |
| Hashimoto, Y; Hirooka, K; Ishida, S; Mori, S; Noda, K; Saito, M; Saito, W | 1 |
| Agard, E; Dot, C; El Chehab, H; Russo, A | 1 |
| Bonaffini, SG; Ma, L; VanderBeek, BL | 1 |
| Izumi-Nagai, K; Nagai, N; Ohta, Y; Ozawa, Y; Shinoda, H; Tsubota, K | 1 |
| Alam, MR; Arcinue, CA; Freeman, WR; Mendoza, NB | 1 |
| Thanos, A; Todorich, B; Trese, MT | 1 |
| Böker, A; Davids, AM; Hager, A; Joussen, AM; Riechardt, AI; Seibel, I | 1 |
| Fraile, JM; Garcia-Martin, E; Mayoral, JA; Otín-Mallada, S; Pablo, LE; Polo-Llorens, V; Prieto, E; Vispe, E | 1 |
| Ghigo, D; Marchese, A; Raffaele, N | 1 |
| Chofflet, J; Hörle, S; Mennel, S; Meyer, SH; Schmidt, JC | 1 |
| Choragiewicz, T; Kiczyńska, M; Mańkowska, A; Oleszczuk, A; Rejdak, R; Zagórski, Z; Łekawa, A | 1 |
| Durmaz, S; Kandemir, N; Kocabora, MS | 1 |
| Covert, DJ; Hur, EY; Kim, JE; Mantravadi, AV | 1 |
| Jun, JH; Kim, KS; Kim, YC | 1 |
| Abraham, P; Bochow, T; Callanan, D; Dyer, D; Lambert, HM; Lee, SY; Potts, SL; Schneiderman, T; Walker, TM | 1 |
| Cervino, AC; Fini, ME; Gerzenstein, SM; Pletcher, MT; Puliafito, CA; Schwartz, SG; Tsinoremas, NF; Young, B | 1 |
| Fechtner, RD; Feuer, WJ; Prenner, JL; Realini, T; Roth, DB; Verma, V | 1 |
| Callanan, DG; Defaller, J; Robin, AL; Sjaarda, RN; Suan, EP | 1 |
| Arita, R; Hasegawa, Y; Hata, Y; Ishibashi, T; Kawahara, S; Kita, T; Kohno, R; Mochizuki, Y | 1 |
| Chang, SD; Hong, KH | 1 |
| Hirano, Y; Nozaki, M; Ogura, Y; Usui, Y; Yasukawa, T | 1 |
| Hirano, Y; Ito, T; Nozaki, M; Ogura, Y; Sakurai, E; Yasukawa, T; Yoshida, M | 1 |
| Jiang, F; Li, X; Peng, C; Sheng, S; Song, Y; Yang, X | 1 |
| Ariga, H; Higuchi, M; Hikichi, T; Kosaka, S; Matsushita, R; Matsushita, T; Ohtsuka, H; Takami, K | 1 |
| Bui, A; Chan, C; Freund, KB; Jain, A; Kertes, PJ; Sarraf, D; Vyas, N | 1 |
| Behar-Cohen, F; Torriglia, A; Valamanesh, F | 1 |
| Akova, YA; Ugurbas, SC | 1 |
| Jonas, JB; Tao, Y | 1 |
| Bartz-Schmidt, KU; Schultheiss, M; Spitzer, MS; Szurman, P; Yörük, E; Ziemssen, F | 1 |
| Bringmann, A; Iandiev, I; Pannicke, T; Reichenbach, A; Uhlmann, S; Wiedemann, P; Wurm, A | 1 |
| Fujioka, C; Furuta, M; Matsubara, H; Matsumoto, T; Matsuura, M; Sasoh, M; Sugimoto, M; Uji, Y; Wada, H | 1 |
| Inoue, M; Ishida, S; Itoh, Y; Kawamura, R; Shinoda, H; Shinoda, K; Tsubota, K | 1 |
| Clark, D; Qureshi, F | 1 |
| Bhatt, SS; Joshi, K; Stepien, KE | 1 |
| Brown, DM; Chen, E; Cox, J; Lin, MY | 1 |
| Grabska-Liberek, I; Jamrozy-Witkowska, A; Jankowska-Lech, I; Kowalska, K; Nowosielska, A; Terelak-Borys, B | 1 |
| Di Giulio, A; Lanzetta, P; Sarao, V; Veritti, D | 1 |
| Bastia, E; Galassi, F; Giambene, B; Impagnatiello, F; Lanzi, C; Masini, E; Ongini, E; Pini, A; Somma, T | 1 |
| Bertelmann, T; Irle, S; Kičová, N; Mennel, S; Sekundo, W | 1 |
| Faghihi, H; Hodjatjalali, K; Khorami, A; Riazi, M | 1 |
| Balakrishna, N; Mansoori, T; Viswanath, K | 1 |
| Ahn, J; Ahn, SJ; Chung, H; Huh, JW; Kim, TW; Yu, HG | 1 |
| Cohen, JH; Cohen, SR; Groth, SL; Herro, A; Pollard, J; Singer, MA; Sponsel, WE | 1 |
| Choi, WS; Chung, IY; Kim, SJ; Kim, YH; Yoo, JM | 1 |
| Chen, TC; Englander, M; Kim, IK; Miller, JW; Paschalis, EI | 1 |
| Alldredge, CD; Garretson, BR | 1 |
| Altaweel, M; Ip, M; Kahana, A | 1 |
| Martinez, JA | 1 |
| Enaida, H; Fujisawa, K; Hata, Y; Hisatomi, T; Ishibashi, T; Miyazaki, M; Nakamura, T; Sakamoto, T; Ueno, A | 1 |
| Barnes, CH; Bowie, EM; Folk, JC | 1 |
| Degenring, RF; Jonas, JB; Kamppeter, B; Kreissig, I | 1 |
| Baumal, CR; Martidis, A; Truong, SN | 1 |
| Lee, WF; Yang, CM | 1 |
| Maranan, L; Ober, MD; Smithen, LM; Spaide, RF | 1 |
| Smithen, LM; Spaide, RF | 1 |
| Gillies, M | 1 |
| Inoue, M; Morita, K; Oguchi, Y; Takeda, K; Tanigawara, Y; Yamada, M | 1 |
| Akkoyun, I; Degenring, R; Jonas, JB; Kreissig, I | 1 |
| Agrawal, J; Agrawal, S; Agrawal, TP | 1 |
| Kroll, P; Meyer, CH; Rodrigues, EB | 1 |
| Gotoh, T; Iijima, H; Imai, M; Imasawa, M; Ohshiro, T | 1 |
| Akkoyun, I; Degenring, RF; Jonas, JB; Kamppeter, BA; Kreissig, I | 1 |
| Erkiliç, K; Ozkiriş, A | 1 |
| Haritoglou, C; Ravalico, G; Sanguinetti, G; Tognetto, D; Zenoni, S | 1 |
| Klais, CM; Spaide, RF | 1 |
| Akar, Y; Barile, GR; Cekiç, O; Chang, S; Schiff, WM; Tseng, JJ | 1 |
| Chatterjee, PR; Datta, H; Mondal, LK; Sarkar, K | 1 |
| Branley, M; Shah, A | 1 |
| Benz, MS; Holz, ER; Kuhl, D; Mieler, WF; Osborn, A; Westfall, AC | 1 |
| Chan, WM; Goh, TY; Lam, DS; Li, KK; Parsons, H | 1 |
| Jonas, JB | 2 |
| Karacorlu, M; Karacorlu, S; Ozdemir, H | 1 |
| D'Amico, DJ; Sobrin, L | 1 |
| Deckers, V; Priem, H; Verbraeken, H | 1 |
| Ugarte, M; Williamson, TH | 1 |
| Inoue, M; Ishida, S; Shinoda, K; Yamaguchi, T | 1 |
| Dhir, L; Prasad, SD | 1 |
| Bessho, K; Cheng, L; Davidson, MC; Freeman, WR; Koh, HJ; Morrison, VL | 1 |
| Jones, R; Rhee, DJ | 1 |
| Albini, TA; Benz, MS; Carvounis, PE; Holz, ER; Iyer, MN; Lakhanpal, RR; Westfall, AC | 1 |
| Konstantopoulos, A; Luff, AJ; Newsom, RS; Williams, CP | 1 |
| Dusová, J; Hejcmanová, D; Korda, V; Rencová, E; Studnicka, J | 1 |
| Conti, SM; Kertes, PJ | 1 |
| Gulati, N; Prenner, J; Roth, DB; Scott, IU | 1 |
| Arbisser, LB; Charles, S; Howcroft, M; Werner, L | 1 |
| Cantor, LB; Gao, H; Oliver, A; Peracha, MO; WuDunn, D | 1 |
| Chen, C; Du, L; Xing, Y | 1 |
| Adams, D; Baird, JH; Bernstein, PS; Hu, J; Li, C; Payne, M; Teske, MP; Wang, C; Yang, Z; Zhang, K | 1 |
| Jonas, JB; Schlichtenbrede, F | 1 |
| Bacsal, K; Chee, SP | 1 |
| Downes, S; Hanson, RJ | 1 |
| Arikan, G; Bajin, FM; Kocak, N; Saatci, AO | 1 |
| Aguni, JS; Farah, ME; Grumann, A; Meyer, CH; Rodrigues, EB; Shiroma, H | 1 |
| Miyake, T; Mizuno, S; Morita, H; Nishiwaki, A; Ogura, Y | 1 |
| Chung, JY; Kaiser, PK; Lowder, CY; Perez, VL; Singh, RP; Taban, M | 1 |
| Arevalo, JF; Berrocal, MH; Garcia, RA; Garcia-Amaris, R; Novoa, LA; Rodríguez, A; Rodriguez, FJ; Sanchez, JG; Wu, L | 1 |
| Chen, SJ; Hsu, WM; Ko, YC; Lau, LI; Lee, FL; Liu, CJ | 1 |
| Chen, FK; Kennedy, C | 1 |
| Cho, GJ; Choi, MY; Choi, WS; Chung, IY; Kang, SS; Kim, YH; Kim, YS; Lee, JH; Park, CH; Yoo, JM | 1 |
| Garg, SP; Sampangi, R; Venkatesh, P | 1 |
| Fechtner, RD; Feuer, WJ; Gloth, J; Green, SN; Heimmel, MR; Radhakrishnan, R; Realini, T; Roth, DB; Yarian, DL | 1 |
| Horgan, N; Marr, B; Shields, CL; Shields, JA; Teixeira, LF | 1 |
| González Barcia, M; Lorenzo Carrero, J; Pérez Flores, I | 1 |
| Hirano, Y; Hirooka, K; Inatani, M; Iwao, K; Kawaji, T; Matsumura, M; Nakanishi, Y; Negi, A; Ogura, Y; Sakamoto, T; Shima, C; Shimonagano, Y; Shiraga, F; Tanihara, H; Yamamoto, H | 1 |
| Ideta, S; Inoue, M; Kawamura, R; Noda, M; Shinoda, K; Tsubota, K | 1 |
| Arévalo, JF; Berrocal, MH; Evans, T; Hsu, M; Rodríguez, FJ; Sánchez, JG; Wu, L | 1 |
| Li, Q; Liu, W; Mo, B; Wang, J; Wang, N; Yang, L; Zeng, H | 1 |
| Ahn, JK; Lee, GH; Park, YG | 1 |
| Ando, N; Berkowitz, BA; de Juan, E; Sen, HA; Wilson, CA | 1 |
| Cai, YS; Heimann, K; Hui, YN; Kirchhof, B; Liang, HC | 1 |
| Duker, JS; Eliott, D; Gragoudas, ES; Haimovici, R; Sjaarda, RN | 1 |
| Greenwald, MA; Vick, VL; Walton, RC | 1 |
| Hisatomi, T; Ishibashi, T; Itaya, K; Miyazaki, M; Nakamura, T; Sakamoto, T; Ueno, A | 1 |
| Chandler, DB; Forbes, VS; Hida, T; Machemer, R; Rozakis, G | 1 |
| Chen, EP; Hatchell, DL; Saloupis, PT; Samsa, GP; Steinhorst, UH | 1 |
| Chandler, DB; de Juan, E; Machemer, R; Rozakis, G | 1 |
| Ishibashi, T; Miki, K; Patterson, R; Ryan, SJ; Sorgente, N | 1 |
| Baruh, E; Gitter, KA; Morgan, CM; Wilkinson, WS | 1 |
| Chandler, DB; Hida, T; Machemer, R; Proia, AD; Sheta, S | 1 |
13 review(s) available for triamcinolone acetonide and Retinal Diseases
| Article | Year |
|---|---|
[Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015].
Topics: Acetazolamide; Adrenal Cortex Hormones; Adult; Animals; Child; Delayed-Action Preparations; Dexamethasone; Dose-Response Relationship, Drug; Drug Implants; Filtering Surgery; Fluocinolone Acetonide; Humans; Intravitreal Injections; Ocular Hypertension; Ointments; Ophthalmic Solutions; Rabbits; Retinal Diseases; Risk Factors; Triamcinolone Acetonide | 2015 |
Three simple approaches to visualize the transparent vitreous cortex during vitreoretinal surgery.
Topics: Blood; Diagnostic Imaging; Eye Diseases; Fluorescein Angiography; Glucocorticoids; Humans; Retinal Diseases; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2008 |
On the retinal toxicity of intraocular glucocorticoids.
Topics: Animals; Anti-Inflammatory Agents; Cell Death; Choroidal Neovascularization; Endothelium, Vascular; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Retina; Retinal Diseases; Retinal Neovascularization; Triamcinolone Acetonide | 2010 |
Intravitreal triamcinolone.
Topics: Glucocorticoids; Humans; Intravitreal Injections; Ocular Hypertension; Ocular Hypotension; Retinal Diseases; Triamcinolone Acetonide | 2011 |
Drug safety evaluation of intravitreal triamcinolone acetonide.
Topics: Animals; Choroid Diseases; Glucocorticoids; Humans; Intravitreal Injections; Retinal Diseases; Risk Assessment; Risk Factors; Treatment Outcome; Triamcinolone Acetonide | 2012 |
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris Diseases; Macular Degeneration; Macular Edema; Ocular Hypotension; Ophthalmia, Sympathetic; Papilledema; Photochemotherapy; Retinal Diseases; Retinal Neovascularization; Retinal Vein Occlusion; Time Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2004 |
Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Topics: Aged; Antihypertensive Agents; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Ocular Hypertension; Prospective Studies; Retinal Diseases; Risk Factors; Time Factors; Triamcinolone Acetonide; Vitreous Body | 2005 |
Controversies in intravitreal triamcinolone acetonide use.
Topics: Choroid Diseases; Glucocorticoids; Humans; Injections; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2005 |
Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature.
Topics: Choroid Diseases; Glaucoma, Open-Angle; Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Retinal Diseases; Risk Factors; Triamcinolone Acetonide | 2006 |
Intravitreal triamcinolone acetonide: a change in a paradigm.
Topics: Animals; Glucocorticoids; Humans; Injections; Retinal Diseases; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2006 |
The use of intravitreal corticosteroids, evidence-based and otherwise.
Topics: Evidence-Based Medicine; Glucocorticoids; Humans; Injections; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2006 |
Management of vitreous loss and dropped nucleus during cataract surgery.
Topics: Cataract Extraction; Glucocorticoids; Humans; Injections; Intraoperative Complications; Lens, Crystalline; Prognosis; Retina; Retinal Diseases; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.
Topics: Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Retinal Diseases; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2008 |
3 trial(s) available for triamcinolone acetonide and Retinal Diseases
| Article | Year |
|---|---|
Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy.
Topics: Basement Membrane; Double-Blind Method; Eye Diseases; Female; Glucocorticoids; Humans; Male; Middle Aged; Preservatives, Pharmaceutical; Retinal Diseases; Suspensions; Treatment Outcome; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2009 |
Intravitreal triamcinolone injection for macular edema secondary to increased retinal vascular permeability.
Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2004 |
Tunneled scleral incision to prevent vitreal reflux after intravitreal injection.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Glucocorticoids; Humans; Injections; Intraoperative Complications; Male; Middle Aged; Prospective Studies; Retinal Diseases; Sclera; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body; Wound Healing | 2007 |
119 other study(ies) available for triamcinolone acetonide and Retinal Diseases
| Article | Year |
|---|---|
Vitreous Cortex Remnants Removal With Beveled Vitrectomy Probe During Vitrectomy For Primary Rhegmatogenous Retinal Detachment.
Topics: Humans; Retinal Detachment; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy | 2023 |
Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
Topics: Dexamethasone; Fluocinolone Acetonide; Glaucoma; Glucocorticoids; Humans; Incidence; Intraocular Pressure; Intravitreal Injections; Macular Edema; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide | 2023 |
TRENDS IN INTRAVITREAL CORTICOSTEROID AGENT USE BY US OPHTHALMOLOGISTS IN MEDICARE BENEFICIARIES AND ASSOCIATION WITH PHYSICIAN-INDUSTRY INTERACTIONS.
Topics: Adult; Dexamethasone; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Medicare; Middle Aged; Ophthalmologists; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; United States; Young Adult | 2021 |
Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Brachytherapy; Choroid Neoplasms; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Male; Melanoma; Middle Aged; Radiation Injuries; Receptors, Vascular Endothelial Growth Factor; Retinal Diseases; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2017 |
Subretinal echinococcosis: a case report.
Topics: Adult; Angiogenesis Inhibitors; Combined Modality Therapy; Echinococcosis; Echinococcosis, Pulmonary; Eye Infections, Parasitic; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Panuveitis; Prednisolone; Ranibizumab; Retinal Diseases; Tomography, Optical Coherence; Tomography, X-Ray Computed; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitrectomy | 2017 |
CLINICAL FINDINGS IN TRIAMCINOLONE-ASSOCIATED MACULOPATHY.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Crystallization; Diabetic Retinopathy; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Microscopy, Electron, Transmission; Middle Aged; Retina; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide | 2019 |
Paraproteinemic Maculopathy in a 63-Year-Old Man.
Topics: Angiogenesis Inhibitors; Bevacizumab; Blood Protein Electrophoresis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Retinal Diseases; Stroke; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity | 2018 |
Optical Coherence Tomography and Management of a Retinal Granuloma in Presumed Ocular Sarcoidosis.
Topics: Diagnosis, Differential; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Granuloma; Humans; Injections, Intraocular; Male; Middle Aged; Retina; Retinal Diseases; Sarcoidosis; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2019 |
Clinical and pathologic features of Bipolaris endophthalmitis after intravitreal triamcinolone.
Topics: Aged; Drug Contamination; Endophthalmitis; Eye Infections, Fungal; Female; Fungi; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Prognosis; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2014 |
Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Müller cell ablation.
Topics: Animals; Cell Death; Ependymoglial Cells; Gliosis; Glucocorticoids; MAP Kinase Signaling System; Mice, Transgenic; Microglia; Mitogen-Activated Protein Kinase 8; Neurodegenerative Diseases; Neuroprotective Agents; Neurotrophin 3; p38 Mitogen-Activated Protein Kinases; Photoreceptor Cells, Vertebrate; Receptors, Nerve Growth Factor; Retinal Diseases; Retinal Vessels; Tamoxifen; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A | 2014 |
Purtscher-like Retinopathy Associated with Systemic Lupus Erythematosus.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Bevacizumab; Cohort Studies; Female; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Intravitreal Injections; Lupus Erythematosus, Systemic; Male; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Young Adult | 2016 |
Long-term trends in intraocular pressure after combined vitrectomy with sub-tenon injection of triamcinolone acetonide.
Topics: Aged; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intraocular; Intraocular Pressure; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Tenon Capsule; Tonometry, Ocular; Triamcinolone Acetonide; Vitrectomy; Vitreous Hemorrhage | 2015 |
Transscleral permeation of subtenon triamcinolone in different vitreoretinal diseases.
Topics: Chromatography, High Pressure Liquid; Diabetic Retinopathy; Epiretinal Membrane; Glucocorticoids; Humans; Permeability; Prospective Studies; Retinal Detachment; Retinal Diseases; Retinal Perforations; Tandem Mass Spectrometry; Tenon Capsule; Triamcinolone Acetonide; Vitrectomy; Vitreoretinal Surgery; Vitreous Body | 2015 |
Highly reflective line in optical coherence tomography images of eyes with macular edema associated with branch retinal vein occlusion.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers; Cross-Sectional Studies; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Photoreceptor Cells, Vertebrate; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema.
Topics: Adult; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Implants; Eye Diseases; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Tissue Adhesions; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2015 |
Increased choroidal blood flow velocity with regression of unilateral acute idiopathic maculopathy.
Topics: Acute Disease; Adult; Blood Flow Velocity; Choroid; Drug Combinations; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Laser-Doppler Flowmetry; Male; Middle Aged; Prednisolone; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2015 |
The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Databases, Factual; Dexamethasone; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Odds Ratio; Retinal Diseases; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2015 |
Sneddon's syndrome with optic disc macroaneurysm and macular edema successfully treated with subtenon steroid injection.
Topics: Aneurysm; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Optic Disk; Retinal Artery; Retinal Diseases; Sneddon Syndrome; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide | 2016 |
RECALCITRANT CYSTOID MACULAR EDEMA AFTER PARS PLANA VITRECTOMY.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Chronic Disease; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Postoperative Complications; Recurrence; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy | 2016 |
A Novel Approach to Understanding Pathogenesis and Treatment of Capillary Dropout in Retinal Vascular Diseases.
Topics: Adolescent; Blood-Retinal Barrier; Capillaries; Capillary Permeability; Drug Therapy, Combination; Endothelium, Vascular; Eye Diseases, Hereditary; Familial Exudative Vitreoretinopathies; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Ophthalmic Solutions; Prednisolone; Retinal Diseases; Retinal Vessels; Triamcinolone Acetonide | 2016 |
Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Implants; Female; Fovea Centralis; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Melanoma; Middle Aged; Proton Therapy; Radiation Injuries; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Uveal Neoplasms; Visual Acuity | 2016 |
Determination of Three Corticosteroids in the Biologic Matrix of Vitreous Humor by HPLC-tandem Mass Spectrometry: Method Development and Validation.
Topics: Animals; Chromatography, High Pressure Liquid; Dexamethasone; Disease Models, Animal; Female; Glucocorticoids; Intravitreal Injections; Methylprednisolone; Rabbits; Retinal Diseases; Tandem Mass Spectrometry; Triamcinolone Acetonide; Vitreous Body | 2017 |
Compared antioxidant activity among corticosteroids on cultured retinal pigment epithelial cells.
Topics: Antioxidants; Cell Survival; Cells, Cultured; Dexamethasone; Glucocorticoids; Humans; Hydro-Lyases; Oxidative Stress; Prednisolone; Retinal Diseases; Retinal Pigment Epithelium; Triamcinolone Acetonide | 2016 |
[Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide].
Topics: Anti-Inflammatory Agents; Blood-Aqueous Barrier; Blood-Retinal Barrier; Case-Control Studies; Epiretinal Membrane; Female; Humans; Inflammation; Male; Postoperative Complications; Prospective Studies; Retinal Diseases; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2008 |
Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.
Topics: Choroid Diseases; Disease Progression; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Detachment; Retinal Diseases; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2008 |
Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Drug Monitoring; Female; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ranibizumab; Retinal Diseases; Retrospective Studies; Time Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |
Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Diseases; Retinal Vessels; Telangiectasis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |
Glucocorticoid receptor polymorphisms and intraocular pressure response to intravitreal triamcinolone acetonide.
Topics: Aged; Female; Genotype; Glucocorticoids; Haplotypes; Humans; Injections; Intraocular Pressure; Introns; Male; Pharmacogenetics; Pilot Projects; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Receptors, Glucocorticoid; Retinal Diseases; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triamcinolone Acetonide; Vitreous Body | 2008 |
Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
Topics: Aged; Antihypertensive Agents; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Male; Ocular Hypertension; Retinal Diseases; Retreatment; Retrospective Studies; Risk Factors; Time Factors; Triamcinolone Acetonide; Vitreous Body | 2009 |
Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Delayed-Action Preparations; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Pregnadienediols; Prospective Studies; Retinal Diseases; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2009 |
Anatomical findings of vitreoretinal interface in eyes with asteroid hyalosis.
Topics: Aged; Aged, 80 and over; Eye Diseases; Female; Glucocorticoids; Humans; Male; Middle Aged; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2009 |
A case of radiation retinopathy of left eye after radiation therapy of right brain metastasis.
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Diagnosis, Differential; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Radiation Injuries; Retina; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide | 2009 |
Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections, Intraocular; Laser Coagulation; Macula Lutea; Male; Middle Aged; Radiology, Interventional; Retinal Diseases; Telangiectasis; Triamcinolone Acetonide; Visual Acuity | 2010 |
Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Administration Routes; Female; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Risk Factors; Tonometry, Ocular; Trabeculectomy; Triamcinolone Acetonide | 2009 |
Accidental macular injury from prolonged viewing of a plasma flash produced by a femtosecond laser.
Topics: Accidents, Occupational; Adult; Eye Injuries; Fluorescein Angiography; Glucocorticoids; Humans; Lasers; Male; Ophthalmoscopy; Retina; Retinal Diseases; Scotoma; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2010 |
Serum concentration of triamcinolone acetonide used for visualisation during vitrectomy.
Topics: Adrenocorticotropic Hormone; Aged; Female; Glucocorticoids; Humans; Male; Retinal Diseases; Triamcinolone Acetonide; Vitrectomy | 2010 |
Triamcinolone-associated crystalline maculopathy.
Topics: Aged; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macula Lutea; Macular Edema; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2010 |
Toxic anterior segment syndrome presenting as isolated cystoid macular edema after removal of entrapped ophthalmic ointment.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Female; Fluorescein Angiography; Humans; Inflammation; Macula Lutea; Macular Edema; Ointments; Phacoemulsification; Postoperative Complications; Retinal Diseases; Triamcinolone Acetonide | 2010 |
[Preservative-free triamcinolone versus purified triamcinolone preparations].
Topics: Female; Humans; Male; Ophthalmia, Sympathetic; Preservatives, Pharmaceutical; Retinal Diseases; Triamcinolone Acetonide | 2011 |
Effects of ischemia-reperfusion on physiological properties of Müller glial cells in the porcine retina.
Topics: Adenosine; Animals; Aquaporin 4; Calcium; Female; Flow Cytometry; Glial Fibrillary Acidic Protein; Gliosis; Glucocorticoids; Immunohistochemistry; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuroglia; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Proto-Oncogene Proteins c-fos; Reperfusion Injury; Retinal Diseases; Retinal Vessels; Swine; Triamcinolone Acetonide | 2011 |
[Case of systemic lupus erythematosus showing visual disturbances resulting from multiple ocular complications].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Diagnostic Techniques, Ophthalmological; Female; Humans; Lupus Erythematosus, Systemic; Macular Edema; Magnetic Resonance Imaging; Methylprednisolone; Optic Neuropathy, Ischemic; Platelet Aggregation Inhibitors; Pulse Therapy, Drug; Retinal Diseases; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders | 2011 |
Incidence of increased intraocular pressure after subtenon injection of triamcinolone acetonide.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Drug Monitoring; Female; Glucocorticoids; Humans; Incidence; Injections, Intraocular; Intraocular Pressure; Japan; Male; Medical Records; Middle Aged; Ocular Hypertension; Refractive Errors; Retinal Diseases; Retrospective Studies; Tenon Capsule; Time Factors; Triamcinolone Acetonide | 2011 |
Macular infarction after inadvertent intracameral cefuroxime.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Cefuroxime; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infarction; Intravitreal Injections; Macular Edema; Medication Errors; Retinal Diseases; Retinal Vessels; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2011 |
Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bacteria; Bevacizumab; Ceftazidime; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vancomycin; Vascular Endothelial Growth Factor A; Vitreous Body | 2011 |
Endophthalmitis after intravitreal injection: the importance of viridans streptococci.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Male; Middle Aged; Ranibizumab; Retinal Diseases; Retrospective Studies; Risk Factors; Streptococcal Infections; Triamcinolone Acetonide; Viridans Streptococci; Visual Acuity; Vitreous Body | 2011 |
[Complications of intravitreal injections--own experience].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctival Diseases; Diabetic Retinopathy; Endophthalmitis; Eye Diseases; Eye Hemorrhage; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Iris Diseases; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Poland; Ranibizumab; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity | 2011 |
The nitric oxide donating triamcinolone acetonide NCX 434 does not increase intraocular pressure and reduces endothelin-1 induced biochemical and functional changes in the rabbit eye.
Topics: Animals; Caspase 3; Cytokines; Electroretinography; Endothelin-1; Glutathione; Hemodynamics; Intraocular Pressure; Intravitreal Injections; Laser-Doppler Flowmetry; Male; Nitrates; Nitric Oxide Donors; Ophthalmic Artery; Optic Disk; Rabbits; Reperfusion Injury; Retina; Retinal Diseases; Superoxide Dismutase; Tonometry, Ocular; Triamcinolone Acetonide; Tyrosine | 2012 |
Evaluation of a posterior vitreous detachment: a comparison of biomicroscopy, B-scan ultrasonography and optical coherence tomography to surgical findings with chromodissection.
Topics: Aged; Aged, 80 and over; Female; Humans; Male; Microscopy, Acoustic; Middle Aged; Posterior Eye Segment; Prospective Studies; Reproducibility of Results; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy; Vitreous Body; Vitreous Detachment | 2012 |
Ultrasound biomicroscopy study of vitreous incarceration subsequent to intravitreal injections.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Eye Diseases; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Microscopy, Acoustic; Middle Aged; Retinal Diseases; Sclerostomy; Triamcinolone Acetonide; Vitreous Body | 2012 |
Incidence and risk factors for secondary ocular hypertension after intravitreal triamcinolone acetonide injection in Asian Indian eyes.
Topics: Adult; Aged; Antihypertensive Agents; Asian People; Female; Follow-Up Studies; Glucocorticoids; Humans; Incidence; India; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Risk Factors; Tonometry, Ocular; Triamcinolone Acetonide | 2013 |
Associated factors and treatment outcome of presumed noninfectious endophthalmitis occurring after intravitreal triamcinolone acetonide injection.
Topics: Aged; Endophthalmitis; Female; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Retinal Diseases; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2013 |
Association of OCT angle recess width with IOP response after intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Female; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Tonometry, Ocular; Triamcinolone Acetonide; Young Adult | 2013 |
Triamcinolone acetonide prevents enhancement of hypoxia-induced neuronal and inducible nitric oxide synthases in the retinas of rats with oxygen-induced retinopathy.
Topics: Animals; Animals, Newborn; Blotting, Western; Disease Models, Animal; Female; Glucocorticoids; Hypoxia; Immunohistochemistry; Neurons; Nitric Oxide Synthase Type II; Oxygen; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Triamcinolone Acetonide | 2012 |
Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
Topics: Academic Medical Centers; Acute Disease; Aged; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Male; Massachusetts; Postoperative Complications; Ranibizumab; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis.
Topics: Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Injections; Middle Aged; Retinal Diseases; Retinal Vessels; Telangiectasis; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study.
Topics: Aged; Edema; Female; Fundus Oculi; Glucocorticoids; Humans; Injections; Macula Lutea; Male; Middle Aged; Retinal Diseases; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2003 |
Intravitreal triamcinolone acetonide for bilateral acquired parafoveal telangiectasis.
Topics: Fluorescein Angiography; Fovea Centralis; Humans; Immunosuppressive Agents; Injections; Male; Middle Aged; Retinal Diseases; Retinal Vessels; Telangiectasis; Triamcinolone Acetonide; Vitreous Body | 2003 |
Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases.
Topics: Aged; Combined Modality Therapy; Female; Glucocorticoids; Humans; Intraocular Pressure; Male; Middle Aged; Postoperative Complications; Reoperation; Retinal Diseases; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2003 |
Corticosteroids, central serous chorioretinopathy, and neurocysticercosis.
Topics: Adult; Albendazole; Anticonvulsants; Antiprotozoal Agents; Body Fluids; Combined Modality Therapy; Drug Therapy, Combination; Exudates and Transudates; Fluorescein Angiography; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Neurocysticercosis; Phenytoin; Prednisolone; Retinal Diseases; Triamcinolone Acetonide; Ventriculoperitoneal Shunt; Vision Disorders; Visual Acuity | 2004 |
Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27-associated iritis.
Topics: Adult; Choroid Diseases; Connective Tissue; Fluorescein Angiography; Glucocorticoids; HLA-B27 Antigen; Humans; Injections; Iritis; Male; Orbit; Prednisolone; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide | 2004 |
Intravitreal triamcinolone acetonide and intraocular pressure.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body | 2004 |
Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.
Topics: Drug Therapy, Combination; Fluorescein Angiography; Humans; Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Diseases; Retinal Neovascularization; Retinal Vessels; Telangiectasis; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body | 2004 |
Is it time yet for intravitreal triamcinolone to be used in routine clinical practice?
Topics: Clinical Trials as Topic; Drug Evaluation; Glucocorticoids; Humans; Injections; Retinal Diseases; Safety; Triamcinolone Acetonide; Vitreous Body | 2004 |
Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
Topics: Aged; Aged, 80 and over; Biological Availability; Chromatography, High Pressure Liquid; Connective Tissue; Drug Administration Routes; Fascia; Glucocorticoids; Humans; Injections; Middle Aged; Retinal Diseases; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2004 |
Safety of intravitreal high-dose reinjections of triamcinolone acetonide.
Topics: Glucocorticoids; Humans; Intraocular Pressure; Prospective Studies; Retinal Diseases; Safety; Time Factors; Triamcinolone Acetonide; Vitreous Body | 2004 |
Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.
Topics: Glucocorticoids; Humans; Injections; Intraocular Pressure; Ocular Hypertension; Retinal Diseases; Trabeculectomy; Treatment Outcome; Triamcinolone Acetonide | 2005 |
Chromovitrectomy: a new field in vitreoretinal surgery.
Topics: Basement Membrane; Coloring Agents; Eye Diseases; Humans; Indocyanine Green; Retinal Diseases; Staining and Labeling; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2005 |
Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.
Topics: Blood; Cataract Extraction; Choroid Diseases; Diabetic Retinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Laser Coagulation; Lens Implantation, Intraocular; Macular Edema; Middle Aged; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitrectomy | 2005 |
Complications of intravitreal injection of triamcinolone acetonide.
Topics: Cataract; Cataract Extraction; Disease Progression; Endophthalmitis; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2005 |
Staining of the internal limiting membrane with intravitreal triamcinolone acetonide.
Topics: Aged; Aged, 80 and over; Basement Membrane; Epiretinal Membrane; Female; Glucocorticoids; Humans; Male; Prospective Studies; Retinal Diseases; Staining and Labeling; Triamcinolone Acetonide; Vitrectomy | 2005 |
Submacular placoid pigment epithelial alteration after resolution of macular edema in central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Decompression, Surgical; Female; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Optic Nerve; Pigment Epithelium of Eye; Postoperative Complications; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity | 2005 |
Cataract progression after intravitreal triamcinolone injection.
Topics: Aged; Aged, 80 and over; Cataract; Choroidal Neovascularization; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Lens, Crystalline; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid.
Topics: Acute Disease; Adult; Blood; Choroid Diseases; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intra-Articular; Retinal Diseases; Tenosynovitis; Triamcinolone Acetonide; Wrist Joint | 2005 |
Use of intravitreal triamcinolone in the management of birdshot retinochoroidopathy associated with cystoid macular oedema: a case study over a three-year period.
Topics: Adult; Choroid Diseases; Chronic Disease; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Retinal Diseases; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Uveitis, Posterior; Visual Acuity; Vitreous Body | 2005 |
Acute endophthalmitis incidence: intravitreal triamcinolone.
Topics: Acute Disease; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Retinal Diseases; Retrospective Studies; Texas; Triamcinolone Acetonide; Vitreous Body | 2005 |
Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis.
Topics: Fovea Centralis; Glucocorticoids; Humans; Injections; Male; Middle Aged; Retinal Diseases; Retinal Vessels; Telangiectasis; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Ultrasonography; Vitreous Body | 2005 |
Intravitreal use of triamcinolone acetonide: an experimental clinical procedure.
Topics: Glucocorticoids; Humans; Injections; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2005 |
Resolution of foveal pseudocyst after intravitreal triamcinolone acetonide.
Topics: Cysts; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Middle Aged; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Vitreous Body | 2005 |
One year of intravitreal injections of steroids.
Topics: Chronic Disease; Drug Administration Schedule; Edema; Endophthalmitis; Female; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Hyperglycemia; Injections; Intraocular Pressure; Male; Retina; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2005 |
Retinal pigment epithelium (RPE) pigmentation and thickening in the central macula after macular edema resolution in central retinal vein occlusion (CRVO).
Topics: Combined Modality Therapy; Decompression, Surgical; Humans; Macula Lutea; Macular Edema; Pigment Epithelium of Eye; Postoperative Complications; Retinal Diseases; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide | 2006 |
Detecting vitreomacular adhesions in eyes with asteroid hyalosis with triamcinolone acetonide.
Topics: Aged; Eye Diseases; Female; Fluorescein Angiography; Glucocorticoids; Humans; Male; Middle Aged; Retinal Diseases; Tissue Adhesions; Triamcinolone Acetonide; Ultrasonography; Visual Acuity; Vitrectomy; Vitreous Body; Vitreous Detachment | 2007 |
IOP after triamcinolone acetonide.
Topics: Glucocorticoids; Humans; Intraocular Pressure; Ocular Hypertension; Retinal Diseases; Time Factors; Triamcinolone Acetonide | 2006 |
Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits.
Topics: Animals; Benzyl Alcohol; Electroretinography; Glucocorticoids; Injections; Pharmaceutical Vehicles; Rabbits; Retina; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2006 |
Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.
Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Retinal Diseases; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2006 |
Ocular morbidity associated with intravitreal triamcinolone acetonide.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Endophthalmitis; Exfoliation Syndrome; Eye Diseases; Female; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Detachment; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2007 |
[The intravitreal application of triamcinolone in the treatment of the macular edema].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Edema; Female; Glucocorticoids; Humans; Injections; Macula Lutea; Male; Middle Aged; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 2006 |
Patient perceptions of discomfort and changes in vision and functional status associated with intravitreal triamcinolone injection.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Pain Measurement; Patient Satisfaction; Patients; Prospective Studies; Retinal Diseases; Triamcinolone Acetonide; Vision, Ocular; Vitreous Body | 2006 |
Intravitreal triamcinolone injection in patients with surgically controlled glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma, Open-Angle; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Retinal Diseases; Trabeculectomy; Triamcinolone Acetonide; Vitreous Body | 2006 |
Filter connected with three-way cock in remove of the vehicle in triamcinolone acetonide.
Topics: Administration, Topical; Adult; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Retinal Diseases; Retinal Vein Occlusion; Triamcinolone Acetonide; Visual Acuity; Vitrectomy; Vitreous Body | 2006 |
Intravitreal injection of triamcinolone acetonide for macular edema due to retinitis pigmentosa and other retinal diseases.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Immunosuppressive Agents; Injections; Macular Edema; Retinal Diseases; Retinitis Pigmentosa; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2006 |
Ocular toxoplasmosis.
Topics: Female; Glucocorticoids; Humans; Middle Aged; Retinal Diseases; Retinal Necrosis Syndrome, Acute; Toxoplasmosis, Ocular; Triamcinolone Acetonide | 2007 |
Conservative management of refractory steroid-induced glaucoma following anterior subtenon steroid injection.
Topics: Adult; Angiomatosis; Connective Tissue; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Retinal Diseases; Triamcinolone Acetonide; von Hippel-Lindau Disease | 2007 |
Combination of photodynamic therapy, intravitreal triamcinolone injection, and standard laser photocoagulation in radiation retinopathy: a case report.
Topics: Fundus Oculi; Glucocorticoids; Graves Disease; Humans; Injections; Laser Coagulation; Light Coagulation; Macula Lutea; Male; Middle Aged; Photochemotherapy; Radiation Injuries; Retinal Diseases; Retreatment; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2006 |
Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina.
Topics: Acridine Orange; Animals; Cell Communication; Disease Models, Animal; Endothelium, Vascular; Fluorescent Dyes; Gene Expression; Glucocorticoids; Injections; Intercellular Adhesion Molecule-1; Ischemia; Leukocytes; Macular Edema; Male; P-Selectin; Rats; Rats, Long-Evans; Retinal Diseases; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triamcinolone Acetonide | 2007 |
Sterile endophthalmitis after intravitreal triamcinolone: a possible association with uveitis.
Topics: Aged; Aged, 80 and over; Endophthalmitis; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body | 2007 |
Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Feasibility Studies; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Edema; Male; Middle Aged; Photochemotherapy; Pilot Projects; Retinal Diseases; Telangiectasis; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Laser trabeculoplasty.
Topics: Adult; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Laser Therapy; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Retinal Diseases; Trabecular Meshwork; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2007 |
Choroidal neovascularization from a presumed subretinal nematode.
Topics: Adult; Choroidal Neovascularization; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Fluorescein Angiography; Glucocorticoids; Humans; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity | 2007 |
Triamcinolone acetonide protects the rat retina from STZ-induced acute inflammation and early vascular leakage.
Topics: Animals; Anti-Inflammatory Agents; Capillary Permeability; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Inflammation; Intercellular Adhesion Molecule-1; Male; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Streptozocin; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2007 |
Natural history of sub-retinal triamcinolone acetonide deposition after triamcinolone-assisted vitrectomy.
Topics: Adolescent; Adult; Child, Preschool; Follow-Up Studies; Glucocorticoids; Granuloma, Foreign-Body; Humans; Male; Pigment Epithelium of Eye; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitrectomy | 2008 |
Short-term complications of intravitreal injection of triamcinolone acetonide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Choroid Diseases; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2008 |
Bilateral retinal vasculopathy in a patient with dyskeratosis congenita.
Topics: Child; Dyskeratosis Congenita; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Laser Coagulation; Male; Retinal Diseases; Retinal Vessels; Stem Cell Transplantation; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Sterile endophthalmitis after benzyl alcohol filtered triamcinolone acetonide injection.
Topics: Aged; Benzyl Alcohol; Endophthalmitis; Female; Filtration; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body | 2008 |
Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Topics: Aged; Case-Control Studies; Connective Tissue; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Retinal Diseases; Retrospective Studies; Risk Factors; Tonometry, Ocular; Triamcinolone Acetonide | 2008 |
Ptosis after sub-Tenon's capsule triamcinolone.
Topics: Blepharoptosis; Connective Tissue; Glucocorticoids; Humans; Retinal Diseases; Retinal Vessels; Triamcinolone Acetonide | 2008 |
Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.
Topics: Aged; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Injections; Male; Middle Aged; Retinal Diseases; Retinal Vessels; Retrospective Studies; Telangiectasis; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
A moephologic study of retinal toxicity induced by triamcinolone acetonide vehicles in rabbit eyes.
Topics: Acetates; Animals; Benzyl Alcohol; Carboxymethylcellulose Sodium; Drug Combinations; Injections; Minerals; Pharmaceutical Vehicles; Polysorbates; Rabbits; Retina; Retinal Diseases; Sodium Chloride; Triamcinolone Acetonide; Vitreous Body | 2008 |
Intravitreal triamcinolone reduces the morphologic changes of ciliary body after pars plana vitrectomy for retinal vascular diseases.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Ciliary Body; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Male; Microscopy, Acoustic; Middle Aged; Postoperative Complications; Prospective Studies; Retinal Diseases; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveal Diseases; Vitrectomy; Vitreous Body | 2008 |
Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy.
Topics: Animals; Blood-Retinal Barrier; Cells, Cultured; Contrast Media; Disease Models, Animal; Eye Diseases; Female; Fibroblasts; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1994 |
Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Carriers; Eye Diseases; Female; Injections; Liposomes; Macrophages; Male; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1993 |
Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Asthma; Beclomethasone; Bronchitis; Choroid Diseases; Exudates and Transudates; Female; Fluorescein Angiography; Fluticasone; Fundus Oculi; Glucocorticoids; Humans; Male; Middle Aged; Pigment Epithelium of Eye; Prospective Studies; Retinal Detachment; Retinal Diseases; Rhinitis; Risk Factors; Triamcinolone Acetonide; Visual Acuity | 1997 |
Sub-tenon's corticosteroids for the treatment of macular edema in bone marrow transplant retinopathy.
Topics: Administration, Topical; Adolescent; Anti-Inflammatory Agents; Bone Marrow Transplantation; Connective Tissue; Fascia; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Retinal Diseases; Triamcinolone Acetonide | 1999 |
Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.
Topics: Blood-Aqueous Barrier; Blood-Retinal Barrier; Female; Humans; Immunosuppressive Agents; Intraocular Pressure; Male; Middle Aged; Postoperative Complications; Retinal Diseases; Triamcinolone Acetonide; Visual Acuity; Vitrectomy | 2002 |
The lack of an effect of intraocular steroids on irradiated fibroblasts in experimental proliferative vitreoretinopathy.
Topics: Animals; Cesium Radioisotopes; Disease Models, Animal; Eye Diseases; Female; Fibroblasts; Injections; Male; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1992 |
The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Eye Diseases; Female; Fibroblasts; Fundus Oculi; Male; Rabbits; Random Allocation; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1992 |
The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Disease Models, Animal; Eye Diseases; Neovascularization, Pathologic; Rabbits; Retinal Detachment; Retinal Diseases; Retinal Perforations; Time Factors; Triamcinolone Acetonide; Vitreous Body | 1985 |
Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate.
Topics: Animals; Dexamethasone; Laser Therapy; Lasers; Macaca fascicularis; Neovascularization, Pathologic; Prostheses and Implants; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1985 |
Retinal and choroidal vascular occlusion secondary to corticosteroid embolisation.
Topics: Adult; Choroid; Embolism; Female; Fluorescein Angiography; Humans; Injections; Phenylephrine; Retinal Diseases; Retinal Vessels; Sinusitis; Triamcinolone Acetonide; Uveal Diseases | 1989 |
Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatment.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Eye Diseases; Fibroblasts; Rabbits; Retinal Detachment; Retinal Diseases; Transplantation, Homologous; Triamcinolone Acetonide; Vitreous Body | 1987 |